Cargando…

Biophysical Characterization and Drug Delivery Potential of Exosomes from Human Wharton’s Jelly-Derived Mesenchymal Stem Cells

[Image: see text] Cell-derived exosomes (30–200 nm) as biological “nanocarriers” have attracted a great deal of interest for therapeutic applications due to their ability to internalize in in vivo biological systems (i.e., cells). Although they can be harvested from various sources including stem ce...

Descripción completa

Detalles Bibliográficos
Autores principales: Chopra, Neha, Dutt Arya, Braham, Jain, Namrata, Yadav, Poonam, Wajid, Saima, Singh, Surinder P., Choudhury, Sangeeta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2019
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6705090/
https://www.ncbi.nlm.nih.gov/pubmed/31460441
http://dx.doi.org/10.1021/acsomega.9b01180
_version_ 1783445574363643904
author Chopra, Neha
Dutt Arya, Braham
Jain, Namrata
Yadav, Poonam
Wajid, Saima
Singh, Surinder P.
Choudhury, Sangeeta
author_facet Chopra, Neha
Dutt Arya, Braham
Jain, Namrata
Yadav, Poonam
Wajid, Saima
Singh, Surinder P.
Choudhury, Sangeeta
author_sort Chopra, Neha
collection PubMed
description [Image: see text] Cell-derived exosomes (30–200 nm) as biological “nanocarriers” have attracted a great deal of interest for therapeutic applications due to their ability to internalize in in vivo biological systems (i.e., cells). Although they can be harvested from various sources including stem cells, yet an appropriate isolation and characterization protocol to obtain “pure” exosomal population is needed. For potential clinical applications, understanding the functional ability of exosomes and their purity, that is, free from microvesicles, apoptotic bodies, and protein aggregates, is a pre-requisite. To achieve high purity and yield of exosomes from human Wharton’s jelly-derived mesenchymal stem cells (hWJ-MSCs) in the size range of 30–200 nm, we have performed and compared three isolation procedures: ultracentrifugation (UC), sucrose cushion (SC), and commercially available reagent (CR). The isolated exosomes were characterized using nanoparticle tracking analysis (NTA), field emission scanning electron microscopy (FESEM), and atomic force microscopy (AFM). Furthermore, to understand the therapeutic potential of the hWJ-MSC-derived exosomes (hWJ-ME) to target pancreatic tumor cells, the internalization efficacy has been evaluated on the MiaPaCa-2 cell lines using confocal microscopy and flow cytometry. The NTA results showed sucrose cushion to be an optimal method for exosome isolation with high purity (86.8%), as compared to UC (40.5%; p = 0.050) and CR (38%; p = 0.050). Optical analysis by FESEM and AFM revealed that SC-isolated exosomes presented a spherical morphology, whereas UC- and CR-isolated exosomes exhibited an uneven morphology. Furthermore, the data from confocal images and flow cytometry showed that hWJ-ME were internalized by MiaPaCa-2, demonstrating the feasibility of exosomes as a “potential nanocarrier”. Thus, our study suggests that a combination of NTA (yield), AFM (dimensions), and FESEM (morphology and topography) could provide sensitive biophysical characterization of hWJ-ME. In the future, enriched exosomes could be used as a delivery vehicle to transport target-specific drugs or gene-silencing constructs to tumors.
format Online
Article
Text
id pubmed-6705090
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher American Chemical Society
record_format MEDLINE/PubMed
spelling pubmed-67050902019-08-27 Biophysical Characterization and Drug Delivery Potential of Exosomes from Human Wharton’s Jelly-Derived Mesenchymal Stem Cells Chopra, Neha Dutt Arya, Braham Jain, Namrata Yadav, Poonam Wajid, Saima Singh, Surinder P. Choudhury, Sangeeta ACS Omega [Image: see text] Cell-derived exosomes (30–200 nm) as biological “nanocarriers” have attracted a great deal of interest for therapeutic applications due to their ability to internalize in in vivo biological systems (i.e., cells). Although they can be harvested from various sources including stem cells, yet an appropriate isolation and characterization protocol to obtain “pure” exosomal population is needed. For potential clinical applications, understanding the functional ability of exosomes and their purity, that is, free from microvesicles, apoptotic bodies, and protein aggregates, is a pre-requisite. To achieve high purity and yield of exosomes from human Wharton’s jelly-derived mesenchymal stem cells (hWJ-MSCs) in the size range of 30–200 nm, we have performed and compared three isolation procedures: ultracentrifugation (UC), sucrose cushion (SC), and commercially available reagent (CR). The isolated exosomes were characterized using nanoparticle tracking analysis (NTA), field emission scanning electron microscopy (FESEM), and atomic force microscopy (AFM). Furthermore, to understand the therapeutic potential of the hWJ-MSC-derived exosomes (hWJ-ME) to target pancreatic tumor cells, the internalization efficacy has been evaluated on the MiaPaCa-2 cell lines using confocal microscopy and flow cytometry. The NTA results showed sucrose cushion to be an optimal method for exosome isolation with high purity (86.8%), as compared to UC (40.5%; p = 0.050) and CR (38%; p = 0.050). Optical analysis by FESEM and AFM revealed that SC-isolated exosomes presented a spherical morphology, whereas UC- and CR-isolated exosomes exhibited an uneven morphology. Furthermore, the data from confocal images and flow cytometry showed that hWJ-ME were internalized by MiaPaCa-2, demonstrating the feasibility of exosomes as a “potential nanocarrier”. Thus, our study suggests that a combination of NTA (yield), AFM (dimensions), and FESEM (morphology and topography) could provide sensitive biophysical characterization of hWJ-ME. In the future, enriched exosomes could be used as a delivery vehicle to transport target-specific drugs or gene-silencing constructs to tumors. American Chemical Society 2019-08-09 /pmc/articles/PMC6705090/ /pubmed/31460441 http://dx.doi.org/10.1021/acsomega.9b01180 Text en Copyright © 2019 American Chemical Society This is an open access article published under an ACS AuthorChoice License (http://pubs.acs.org/page/policy/authorchoice_termsofuse.html) , which permits copying and redistribution of the article or any adaptations for non-commercial purposes.
spellingShingle Chopra, Neha
Dutt Arya, Braham
Jain, Namrata
Yadav, Poonam
Wajid, Saima
Singh, Surinder P.
Choudhury, Sangeeta
Biophysical Characterization and Drug Delivery Potential of Exosomes from Human Wharton’s Jelly-Derived Mesenchymal Stem Cells
title Biophysical Characterization and Drug Delivery Potential of Exosomes from Human Wharton’s Jelly-Derived Mesenchymal Stem Cells
title_full Biophysical Characterization and Drug Delivery Potential of Exosomes from Human Wharton’s Jelly-Derived Mesenchymal Stem Cells
title_fullStr Biophysical Characterization and Drug Delivery Potential of Exosomes from Human Wharton’s Jelly-Derived Mesenchymal Stem Cells
title_full_unstemmed Biophysical Characterization and Drug Delivery Potential of Exosomes from Human Wharton’s Jelly-Derived Mesenchymal Stem Cells
title_short Biophysical Characterization and Drug Delivery Potential of Exosomes from Human Wharton’s Jelly-Derived Mesenchymal Stem Cells
title_sort biophysical characterization and drug delivery potential of exosomes from human wharton’s jelly-derived mesenchymal stem cells
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6705090/
https://www.ncbi.nlm.nih.gov/pubmed/31460441
http://dx.doi.org/10.1021/acsomega.9b01180
work_keys_str_mv AT chopraneha biophysicalcharacterizationanddrugdeliverypotentialofexosomesfromhumanwhartonsjellyderivedmesenchymalstemcells
AT duttaryabraham biophysicalcharacterizationanddrugdeliverypotentialofexosomesfromhumanwhartonsjellyderivedmesenchymalstemcells
AT jainnamrata biophysicalcharacterizationanddrugdeliverypotentialofexosomesfromhumanwhartonsjellyderivedmesenchymalstemcells
AT yadavpoonam biophysicalcharacterizationanddrugdeliverypotentialofexosomesfromhumanwhartonsjellyderivedmesenchymalstemcells
AT wajidsaima biophysicalcharacterizationanddrugdeliverypotentialofexosomesfromhumanwhartonsjellyderivedmesenchymalstemcells
AT singhsurinderp biophysicalcharacterizationanddrugdeliverypotentialofexosomesfromhumanwhartonsjellyderivedmesenchymalstemcells
AT choudhurysangeeta biophysicalcharacterizationanddrugdeliverypotentialofexosomesfromhumanwhartonsjellyderivedmesenchymalstemcells